RANI logo

RANI
Rani Therapeutics Holdings Inc - Ordinary Shares Class A

2,158
Mkt Cap
$91.53M
Volume
1.18M
52W High
$3.87
52W Low
$0.387
PE Ratio
-1.26
RANI Fundamentals
Price
$0.74
Prev Close
$0.78
Open
$0.795
50D MA
$1.17
Beta
1.58
Avg. Volume
1.37M
EPS (Annual)
-$0.4486
P/B
2.19
Rev/Employee
$23,000.00
$52.20
Loading...
Loading...
News
all
press releases
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five brokerages that are currently covering the company...
MarketBeat·11d ago
News Placeholder
More News
News Placeholder
Canaccord Genuity Group Lowers Rani Therapeutics (NASDAQ:RANI) Price Target to $5.00
Canaccord Genuity Group lowered their target price on Rani Therapeutics from $9.00 to $5.00 and set a "buy" rating for the company in a report on Wednesday...
MarketBeat·11d ago
News Placeholder
Equities Analysts Offer Predictions for RANI Q1 Earnings
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Free Report) - HC Wainwright issued their Q1 2026 earnings per share estimates for shares of Rani Therapeutics in a report issued on Friday, March...
MarketBeat·13d ago
News Placeholder
Rani Therapeutics (NASDAQ:RANI) Given "Buy" Rating at HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $11.00 price target on shares of Rani Therapeutics in a research report on Friday...
MarketBeat·16d ago
News Placeholder
Rani Therapeutics Q4 Earnings Call Highlights
Rani Therapeutics (NASDAQ:RANI) executives highlighted what they described as a transformational 2025 during the company's fourth-quarter and full-year earnings call, pointing to progress advancing...
MarketBeat·17d ago
News Placeholder
Rani Therapeutics (NASDAQ:RANI) Announces Quarterly Earnings Results
Rani Therapeutics (NASDAQ:RANI - Get Free Report) posted its earnings results on Thursday. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.02). The...
MarketBeat·17d ago
News Placeholder
Rani Therapeutics (RANI) Expected to Announce Earnings on Monday
Rani Therapeutics (NASDAQ:RANI) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-rani-therapeutics-holdings-inc-stock...
MarketBeat·20d ago
News Placeholder
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Recommendation of "Moderate Buy" from Brokerages
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) has earned an average recommendation of "Moderate Buy" from the five analysts that are presently covering the stock, MarketBeat...
MarketBeat·2mo ago
News Placeholder
Rani Therapeutics (NASDAQ:RANI) Trading 1.6% Higher - Time to Buy?
Rani Therapeutics (NASDAQ:RANI) Trading Up 1.6% - Here's Why...
MarketBeat·2mo ago
News Placeholder
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of "Moderate Buy" by Brokerages
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) has received an average rating of "Moderate Buy" from the five ratings firms that are covering the stock, MarketBeat.com reports. One...
MarketBeat·3mo ago
<
1
2
...
>

Latest RANI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.